NEW YORK, Dec. 1, 2010 /PRNewswire/ -- Envy Medical, Inc., the creator of the Lumixyl™ Topical Brightening System, is pleased to unveil a new Lumixyl experience video featuring Ann Marie, a patient of Dr. Ashish Bhatia, renowned dermatologist at Northwestern University: The video can be viewed at http://wp.me/PKC3u-2t. Ann Marie began using the Lumixyl™ Brightening System, a multi-faceted approach, to effectively treat hyperpigmentation and acne scars.
The Lumixyl™ System is a non-toxic, non-irritating, synthetic peptide technology that is clinically proven to significantly improve the appearance of unwanted discoloration, age spots, sun spots and uneven skin tone. Developed by dermatological researchers at Stanford University, Lumixyl's ground-breaking Decapeptide-12 is the only peptide shown to measurably aid the skin in restraining tyrosinase, the enzyme responsible for initiating the overproduction of melanin—which can cause uneven pigmentation and dark spots.
As is often the case, Ann Marie lost all confidence after years of battling acne-induced hyperpigmentation. Because of the condition her skin was in, she hardly smiled. Frustrated with products that weren't working to remove acne and dark spots on her face, Ann Marie turned to Dr. Bhatia and learned about the Lumixyl™ Brightening System.
Ann Marie used the Lumixyl System for eight weeks and experienced results that restored her confidence – and her smile. Unlike other products, Lumixyl™ did not irritate her skin and yielded visible results. An innovation in skin brightening technology, the Lumixyl Brightening System contains four products that work synergistically to target existing hyperpigmentation and prevent its recurrence. For most patients, these formulations can eliminate the need to use hydroquinone based products, which are still commonly used in the US, but controversial due to their potential for side effects. Lumixyl products are proven to be powerful but gentle on skin and can be used on all skin types.
"The results that Ann Marie got are spectacular," commented Dr. Bhatia. "Until now we really haven't had anything that works so effectively on hyperpigmentation and discolored skin."
The Lumixyl Topical Brightening System is based on four products including Active-Prep Cleanser, the Topical Brightening Creme, GlycoPeel 20 Rapid Exfoliating Lotion, and Moisture-Lock Sunscreen SPF 30. The products are ideal for all skin types. Lumixyl Brightening System retails for $270 for four full size products.
Developed by Envy Medical, Inc. and dermatological researchers at Stanford University, Lumixyl products are made exclusively for dermatologists, plastic surgeons and skin oriented aesthetic physicians. The products are manufactured and sold by Envy Medical in the United States and distributed internationally by Toronto, Canada-based Basis Medical Technologies.
ABOUT ENVY MEDICAL — Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company's lead products include SilkPeel®, a breakthrough device combining exfoliation with dermalinfusion® for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available as a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage. More information can be found at www.envymedical.com.
For more information on Lumixyl or to locate a dispensing physician near you, please contact: firstname.lastname@example.org (within the US).
SOURCE Envy Medical, Inc.